A Study in Chronic Hepatitis B e-Antigen Negative Participants After Discontinuation of Nucleos(t)Ide Analog (NA) Treatment
Clinical trial NCT05550519 · WITHDRAWN
Trial details
- NCT number
- NCT05550519
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- WITHDRAWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-31
- Primary completion
- 2025-08-25
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.